Spirig Pharma Ltd. Report issue

For profit Phase 2
Founded: Olten Switzerland (1948)
Status: Acquired by Galderma (2012) → now Nestle (2014)

Organization Overview

First Clinical Trial
2012
NCT01583816
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 2 Trials (2)

resiquimod (2 trials)

sertaconazole (ertaczo) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Carcinoma (Phase 2)

Carcinoma, Basal Cell (Phase 2)

Dermatitis (Phase 2)

Dermatitis, Atopic (Phase 2)

Eczema (Phase 2)

Keratosis (Phase 2)

Keratosis, Actinic (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 3
  • # of Trial APIs: 2